Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1982 Apr;13(4):529–532. doi: 10.1111/j.1365-2125.1982.tb01416.x

Haemodynamic effects of BM 10.188, a new orally active inotropic agent, in healthy volunteers.

B Whiting, A W Kelman, D J Sumner, W S Hillis, H Ledermann
PMCID: PMC1402041  PMID: 7066168

Abstract

1 BM 10.188 (Doxaminol, Boehringer Mannheim, GmbH) is a recently developed beta-sympathomimetic agent which has shown promising positive inotropic activity in experimental animal models. It is a dibenzoxepine derivative. 2 The effects of 20 mg oral BM 10.188 on systolic time intervals and standard echocardiographic parameters have been studied in six normal healthy male volunteers. 3 When assessed by repeated measured analysis of variance, QS2 and LVET shortened significantly (P less than 0.005) in the 8 h period following BM 10.188. Mean maximum shortening values were: QS2, 25.7 +/- 25.6 (s.d.) ms at 155 min and LVET, 10.7 +/- 9.5 (s.d.) ms at 155 min. There was a corresponding small but significant increase of 4.2 +/- 3.9 (s.d.) ml in stroke volume at 6 h (P less than 0.025). 4 These results indicate that in normal volunteers, BM 10.188 exhibits effects on noninvasive cardiological indices similar to those observed after cardiac glycosides.

Full text

PDF
529

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Das G. P., Talmers R. N., Weissler A. M. Comparative pharmacodynamics of betamethyl digoxin and digoxin in man. Clin Pharmacol Ther. 1977 Sep;22(3):280–285. doi: 10.1002/cpt1977223280. [DOI] [PubMed] [Google Scholar]
  2. Gibson D. G. Use of M-mode echocardiography in clinical pharmacology. Br J Clin Pharmacol. 1979 May;7(5):443–449. doi: 10.1111/j.1365-2125.1979.tb00984.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Gibson D. G. Use of the systolic time intervals in clinical pharmacology. Br J Clin Pharmacol. 1978 Aug;6(2):97–102. doi: 10.1111/j.1365-2125.1978.tb00832.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Harris W. S., Schoenfeld C. D., Brooks R. H., Weissler A. M. Effect of beta adrenergic blockade on the hemodynamic responses to epinephrine in man. Am J Cardiol. 1966 Apr;17(4):484–492. doi: 10.1016/0002-9149(66)90238-4. [DOI] [PubMed] [Google Scholar]
  5. Hutton I., Hillis W. S., Langhan C. E., Conely J. M., Lawrie T. D. Cardiovascular effects of a new inotropic agent, U. K. 14275, in patients with coronary heart disease. Br J Clin Pharmacol. 1977 Oct;4(5):513–517. doi: 10.1111/j.1365-2125.1977.tb00778.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hutton I., Murray R. G., Boyes R. N., Rae A. P., Hillis W. S. Haemodynamic effects of prenalterol in patients with coronary heart disease. Br Heart J. 1980 Feb;43(2):134–137. doi: 10.1136/hrt.43.2.134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kelman A. W., Sumner D. J., Lawrence J. R., Whiting B. Measurement of systolic time intervals. Br J Clin Pharmacol. 1978 Dec;6(6):549–550. doi: 10.1111/j.1365-2125.1978.tb00886.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kelman A. W., Sumner D. J., Lonsdale M., Lawrence J. R., Whiting B. Comparative pharmacokinetics and pharmacodynamics of cardiac glycosides. Br J Clin Pharmacol. 1980 Aug;10(2):135–143. doi: 10.1111/j.1365-2125.1980.tb01730.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kelman A. W., Sumner D. J., Whiting B. Systolic time interval v heart rate regression equations using atropine: reproducibility studies. Br J Clin Pharmacol. 1981 Jul;12(1):15–20. doi: 10.1111/j.1365-2125.1981.tb01849.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Lewis R. P., Boudoulas H., Forester W. F., Weissler A. M. Shortening of electromechanical systole as a manifestation of excessive adrenergic stimulation in acute myocardial infarction. Circulation. 1972 Nov;46(5):856–862. doi: 10.1161/01.cir.46.5.856. [DOI] [PubMed] [Google Scholar]
  11. Teichholz L. E., Kreulen T., Herman M. V., Gorlin R. Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy. Am J Cardiol. 1976 Jan;37(1):7–11. doi: 10.1016/0002-9149(76)90491-4. [DOI] [PubMed] [Google Scholar]
  12. WEISSLER A. M., KAMEN A. R., BORNSTEIN R. S., SCHOENFELD C. D., COHEN S. THE EFFECT OF DESLANOSIDE ON THE DURATION OF THE PHASES OF VENTRICULAR SYSTOLE IN MAN. Am J Cardiol. 1965 Feb;15:153–161. doi: 10.1016/0002-9149(65)90449-2. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES